Back to News
Market Impact: 0.25
Bausch + Lomb Announces European CE Mark Approval Of SeeLyra; To Seek Approvals Around The World
Source: Nasdaq
Healthcare & BiotechProduct LaunchesRegulation & LegislationTechnology & Innovation
Bausch + Lomb received European CE Mark approval for SeeLyra, its next-generation femtosecond laser. The product will launch on a limited basis in Europe in the coming months, with broader availability expected in 2027, supporting the company's ophthalmic surgical technology pipeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
BLCO0.65
More News
- Nvidia in talks to invest up to $10 billion in Anthropic IPO
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Exclusive-Nvidia in talks to invest in Anthropic’s mega IPO, sources say
- Why ACV Stock Rocketed 44% Higher Today
- Surging cloud revenue boosted Oracle’s quarterly results. Here’s what analysts are saying
- Oracle jumps 6% after reporting 30% revenue growth fueled by AI cloud demand